Peptide Atlas · Peptide

Ipamorelin

Ipamorelin is the pentapeptide Aib-His-D-2-Nal-D-Phe-Lys-NH2, described as the first selective growth hormone secretagogue; it releases growth hormone through a GHRP-like receptor with potency and efficacy similar to GHRP-6.

emerging

provisional
PubChem 9831659
2 citations
0 discussions
0 followers

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Evidence, kept apart

The Atlas never mixes evidence types into one blob. Each claim below carries the tier it actually sits in; an unresolved citation is shown and does not move the page.

Evidence map for Ipamorelin. Tier reflects study design, not enthusiasm.
Claim	Tier	Source
Phase 2 randomized trial in postoperative ileus: no significant difference from placebo	emerging	pmid 25331030
Development and pharmacology of ipamorelin	preclinical	pmid 9849822

Unanswered questions

No open questions on file. Either everything about this molecule is known, or nobody has admitted what is not.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.